Sign in

CIK 0001728117 · Non-accelerated filer<br>Smaller reporting company

Gossamer Bio, Inc.

Sign in to watch
Ticker
GOSS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
475461709
Phone
(858) 684-1300
Business address
3115 MERRYFIELD ROW, SUITE 120, SAN DIEGO, CA, 92121
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 6 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-06-09 Burow Kristina Director Grant or award · Stock Option (Right to Buy) +30,000 30,000
2022-06-09 Daniel Thomas O Director Grant or award · Stock Option (Right to Buy) +30,000 30,000
2022-06-09 Cox Russell J. Director Grant or award · Stock Option (Right to Buy) +30,000 30,000
2022-06-09 Bilenker Joshua H. Director Grant or award · Stock Option (Right to Buy) +30,000 30,000
2022-06-09 Milligan Sandra Director Grant or award · Stock Option (Right to Buy) +30,000 30,000
2022-06-09 GALA RENEE D Director Grant or award · Stock Option (Right to Buy) +30,000 30,000
2022-05-04 Carter Laura Chief Scientific Officer Sale −1,262 $7.20 $9K 89,042
2022-03-23 Christian Waage EVP, Tech Ops and Admin Sale −10,722 $8.92 $96K 579,008
2022-03-23 Hasnain Faheem President & CEO Sale −19,035 $8.92 $170K 143,465
2022-03-23 Giraudo Bryan COO/CFO Sale −10,722 $8.92 $96K 99,167
2022-03-16 Carter Laura Chief Scientific Officer Sale −5,002 $8.28 $41K 90,304
2022-03-16 Peterson Caryn EVP, Regulatory Affairs Sale −6,279 $8.28 $52K 66,172
2022-03-16 Aranda Richard Chief Medical Officer Sale −6,278 $8.28 $52K 211,675
2022-01-06 Carter Laura Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +190,000 190,000
2022-01-06 Peterson Caryn EVP, Regulatory Affairs Grant or award · Stock Option (Right to Buy) +190,000 190,000
2022-01-06 Aranda Richard Chief Medical Officer Grant or award · Stock Option (Right to Buy) +190,000 190,000
2022-01-06 Christian Waage EVP & General Counsel Grant or award · Stock Option (Right to Buy) +190,000 190,000
2022-01-06 Giraudo Bryan COO/CFO Grant or award · Stock Option (Right to Buy) +265,000 265,000
2022-01-06 Hasnain Faheem President & CEO Grant or award · Stock Option (Right to Buy) +650,000 650,000
2021-10-25 Peterson Caryn EVP, Regulatory Affairs Sale −2,377 $12.25 $29K 72,451

Page 15 of 21 · 401 trades